Thalomid and Haemoglobin abnormal - a phase IV clinical study of FDA data

Summary:

Haemoglobin abnormal is reported as a side effect among people who take Thalomid (thalidomide), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Dexamethasone, and have Chronic lymphocytic leukaemia recurrent.

The phase IV clinical study analyzes which people have Haemoglobin abnormal when taking Thalomid. It is created by eHealthMe based on reports of 38,055 people who have side effects when taking Thalomid from the FDA, and is updated regularly.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.

What is Haemoglobin abnormal?

Haemoglobin abnormal is found to be associated with 617 drugs and 1,008 conditions by eHealthMe. Check the latest studies of Haemoglobin abnormal.

On Aug, 09, 2026

38,055 people reported to have side effects when taking Thalomid.
Among them, 21 people (0.06%) have Haemoglobin abnormal.

Could Thalomid cause Haemoglobin abnormal?

Among these 21 people:

How long have people been on Thalomid when they have Haemoglobin abnormal? *

What is the gender of people who have Haemoglobin abnormal when taking Thalomid? *

female: 10 %
male: 90 %

What is the age of people who have Haemoglobin abnormal when taking Thalomid? *

What are other drugs people take besides Thalomid? *

What are other side effects people have besides Haemoglobin abnormal? *

Fatigue (feeling of tiredness): 16 people, 76.19%
Constipation: 12 people, 57.14%
Weakness: 11 people, 52.38%
Malaise (a feeling of general discomfort or uneasiness): 10 people, 47.62%
Peripheral Sensory Neuropathy (damage to one or more of your peripheral nerves): 8 people, 38.10%
Oedema (fluid collection in tissue): 5 people, 23.81%
Fever: 5 people, 23.81%
Hyperglycemia (high blood sugar): 5 people, 23.81%
Pneumonia: 5 people, 23.81%
Headache (pain in head): 5 people, 23.81%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 4 people, 19.05%
Prostatic Intraepithelial Neoplasia (prostate cancer): 2 people, 9.52%
Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 2 people, 9.52%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 1 person, 4.76%
Prostate Cancer: 1 person, 4.76%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 4.76%
Malignant Melanoma (skin cancer rises from melancytes): 1 person, 4.76%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 4.76%
Hepatic Neoplasm Malignant (liver cancer): 1 person, 4.76%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Thalomid and have Haemoglobin abnormal?

- Check whether Haemoglobin abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Thalomid:

Thalomid (38,099 reports)

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (617 drugs)

Browse all the conditions that are associated with Haemoglobin abnormal:

Haemoglobin abnormal (1,008 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on thalidomide (the active ingredients of Thalomid) and Thalomid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.